EOMES对慢性淋巴细胞白血病中CD8+T细胞抗肿瘤活性至关重要
全基因组关联研究发现影响转录因子EOMES的SNP与慢性淋巴细胞白血病(CLL)风险显著增加相关。表观遗传学、RNA测序和流式细胞术显示EOMES不在CLL细胞中表达,而在CD8+T细胞中表达。研究提出EOMES SNP可能通过负向影响CD8+T细胞介导的CLL免疫控制来增加CLL风险,并发现CLL患者CD8+T细胞中EOMES表达高于健康个体,PD-1+EOMES+CD8+T细胞在淋巴结中积累,Eomes缺陷导致CD8+T细胞扩增受损并减弱小鼠CLL控制。
要点
- EOMES在CLL细胞中不表达,而在CD8+T细胞中表达。
- CLL患者CD8+T细胞EOMES表达高于健康个体,PD-1+EOMES+CD8+T细胞在淋巴结积累。
- Eomes缺陷导致CD8+T细胞扩增受损并减弱小鼠CLL控制。
核心结论
- EOMES对CD8+T细胞扩增和/或维持至关重要,因此参与CLL的适应性免疫控制。
研究设计与样本
- 研究采用表观遗传学分析、RNA测序和流式细胞术,并在白血病Eµ-TCL1小鼠中观察EOMES+CD8+T细胞。
主要发现
- CLL患者CD8+T细胞中EOMES表达高于健康个体。
- CLL中PD-1+EOMES+CD8+T细胞在淋巴结而非血液或骨髓中积累。
- 白血病Eµ-TCL1小鼠脾脏中EOMES+CD8+T细胞扩增。
- EOMES表达在表达抑制性受体的CD8+T细胞中最高。
- Eomes缺陷导致CD8+T细胞扩增受损并减弱小鼠CLL控制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Genome-wide association studies identified a single-nucleotide polymorphism (SNP) affecting the transcription factor Eomesodermin (EOMES) associated with a significantly increased risk to develop chronic lymphocytic leukemia (CLL). Epigenetic analyses, RNA sequencing, and flow cytometry revealed that EOMES is not expressed in CLL cells, but in CD8+ T cells for which EOMES is a known master regulator. We thus hypothesized that the increased CLL risk associated with the EOMES SNP might be explained by its negative impact on CD8+ T-cell-mediated immune control of CLL. Flow cytometry analyses revealed a higher EOMES expression in CD8+ T cells of CLL patients compared to healthy individuals, and an accumulation of PD-1+ EOMES+ CD8+ T cells in lymph nodes rather than blood or bone marrow in CLL. This was in line with an observed expansion of EOMES+ CD8+ T cells in the spleen of leukemic Eµ-TCL1 mice. As EOMES expression was highest in CD8+ T cells that express inhibitory receptors, an involvement of EOMES in T-cell exhaustion and dysfunction seems likely. Interestingly, Eomes-deficiency in CD8+ T cells resulted in their impaired expansion associated with decreased CLL control in mice. Overall, these observations suggest that EOMES is essential for CD8+ T-cell expansion and/or maintenance, and therefore involved in adaptive immune control of CLL.
引用
- Llaó-Cid L, Roessner PM, Chapaprieta V, et al. EOMES is essential for antitumor activity of CD8+ T cells in chronic lymphocytic leukemia. Leukemia. 2021. PMID: 33731848. doi:10.1038/s41375-021-01198-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。